Development of Persister-FACSeq: a method to massively parallelize quantification of persister physiology and its heterogeneity

Scientific Reports

Volumn 6, Issue 1, 2016, Pages

  Henry, Theresa C ^a,b   Brynildsen, Mark P ^a,c  

^a PRINCETON UNIVERSITY   (United States)

^b RUTGERS ROBERT WOOD JOHNSON MEDICAL SCHOOL   (United States)

^c Princeton University   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL INFECTION; DRUG TOLERANCE; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HIGH THROUGHPUT SEQUENCING; ISOLATION AND PURIFICATION; MICROBIOLOGICAL EXAMINATION; MICROBIOLOGY; PHYSIOLOGY; PROCEDURES;

BACTERIAL INFECTIONS; BACTERIOLOGICAL TECHNIQUES; DRUG TOLERANCE; ESCHERICHIA COLI; FLOW CYTOMETRY; GENE EXPRESSION PROFILING; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING;

EID: 85009344605     PISSN: None     EISSN: 20452322     Source Type: Journal    
DOI: 10.1038/srep25100     Document Type: Article

References (59)

1. Klevens, R. M. et al. Estimating health care-associated infections and deaths in US hospitals, 2002. Public Health Rep. 122, 160–166 (2007).
2. Stone, P. W. Economic burden of healthcare-associated infections: an American perspective. Expert Rev. Pharmacoecon. Outcomes Res. 9, 417–422 (2009).
3. Lewis, K. Persister cells. Annu. Rev. Microbiol. 64, 357–372 (2010).
4. Allison, K. R., Brynildsen, M. P. & Collins, J. J. Heterogeneous bacterial persisters and engineering approaches to eliminate them. Curr. Opin. Microbiol. 14, 593–598 (2011).
5. Fauvart, M., De Groote, V. N. & Michiels, J. Role of persister cells in chronic infections: clinical relevance and perspectives on anti-persister therapies. J. Med. Microbiol. 60, 699–709 (2011).
6. Balaban, N. Q. Persistence: mechanisms for triggering and enhancing phenotypic variability. Curr. Opin. Genet. Dev. 21, 768–775 (2011).
7. Gefen, O., Gabay, C., Mumcuoglu, M., Engel, G. & Balaban, N. Q. Single-cell protein induction dynamics reveals a period of vulnerability to antibiotics in persister bacteria. Proc. Natl. Acad. Sci. 105, 6145–6149 (2008).
8. Allison, K. R., Brynildsen, M. P. & Collins, J. J. Metabolite-enabled eradication of bacterial persisters by aminoglycosides. Nature. 473, 216–220 (2011).
9. Balaban, N. Q., Merrin, J., Chait, R., Kowalik, L. & Leibler, S. Bacterial persistence as a phenotypic switch. Science. 305, 1622–1625 (2004).
10. Maisonneuve, E., Castro-Camargo, M. & Gerdes, K. (p)ppGpp controls bacterial persistence by stochastic induction of toxin-antitoxin activity. Cell. 154, 1140–1150 (2013).
11. Germain, E., Roghanian, M., Gerdes, K. & Maisonneuve, E. Stochastic induction of persister cells by HipA through (p)ppGpp-mediated activation of mRNA endonucleases. Proc. Natl. Acad. Sci. 112, 5171–5176 (2015).
12. Vega, N. M., Allison, K. R., Khalil, A. S. & Collins, J. J. Signaling-mediated bacterial persister formation. Nat. Chem. Biol. 8, 431–433 (2012).
13. Shah, D. et al. Persisters: a distinct physiological state of E. coli. BMC Microbiol. 6, 53 (2006).
14. Orman, M. A. & Brynildsen, M. P. Dormancy is not necessary or sufficient for bacterial persistence. Antimicrob. Agents Chemother. 57, 3230–3239 (2013).
15. Roostalu, J., Joers, A., Luidalepp, H., Kaldalu, N. & Tenson, T. Cell division in Escherichia coli cultures monitored at single cell resolution. BMC Microbiol. 8, 68 (2008).
16. Orman, M. A. & Brynildsen, M. P. Establishment of a method to rapidly assay bacterial persister metabolism. Antimicrob. Agents Chemother. 57, 4398–4409 (2013).
17. Oliver, J. D. The viable but nonculturable state in bacteria. J. Microbiol. 43, 93–100 (2005).
18. Asakura, H. et al. Differential expression of the outer membrane protein W (OmpW) stress response in enterohemorrhagic Escherichia coli O157:H7 corresponds to the viable but non-culturable state. Res. Microbiol. 159, 709–717 (2008).
19. Nystrom, T. Not quite dead enough: on bacterial life, culturability, senescence and death. Arch. Microbiol. 176, 159–164 (2001).
20. Joers, A., Kaldalu, N. & Tenson, T. The frequency of persisters in Escherichia coli reflects the kinetics of awakening from dormancy. J. Bacteriol. 192, 3379–3384 (2010).
21. Mizunoe, Y., Wai, S. N., Takade, A. & Yoshida, S. Restoration of culturability of starvation-stressed and low-temperature-stressed Escherichia coli O157 cells by using H2O2-degrading compounds. Arch. Microbiol. 172, 63–67 (1999).
22. Keren, I., Shah, D., Spoering, A., Kaldalu, N. & Lewis, K. Specialized persister cells and the mechanism of multidrug tolerance in Escherichia coli. J. Bacteriol. 186, 8172–8180 (2004).
23. Keren, I., Minami, S., Rubin, E. & Lewis, K. Characterization and transcriptome analysis of Mycobacterium tuberculosis persisters. mBio. 2, e00100–11 (2011).
24. Canas-Duarte, S. J., Restrepo, S. & Pedraza, J. M. Novel protocol for persister cells isolation. PLoS One. 9, e88660 (2014).
25. Amato, S. M., Orman, M. A. & Brynildsen, M. P. Metabolic control of persister formation in Escherichia coli. Mol. Cell. 50, 475–487 (2013).
26. Ma, C. et al. Energy production genes sucB and ubiF are involved in persister survival and tolerance to multiple antibiotics and stresses in Escherichia coli. FEMS Microbiol. Lett. 303, 33–40 (2010).
27. Levin, B. R., Concepcion-Acevedo, J. & Udekwu, K. I. Persistence: a copacetic and parsimonious hypothesis for the existence of non-inherited resistance to antibiotics. Curr. Opin. Microbiol. 21, 18–21 (2014).
28. Keren, I., Kaldalu, N., Spoering, A., Wang, Y. & Lewis, K. Persister cells and tolerance to antimicrobials. FEMS Microbiol. Lett. 230, 13–18 (2004).
29. Nadell, C. D., Xavier, J. B. & Foster, K. R. The sociobiology of biofilms. FEMS Microbiol. Rev. 33, 206–224 (2009).
30. Zhao, X. et al. Lethal action of quinolones against a temperature-sensitive dnaB replication mutant of Escherichia coli. Antimicrob. Agents Chemother. 50, 362–364 (2006).
31. Blondeau, J. M. Fluoroquinolones: Mechanism of action, classification and development of resistance. Surv. Ophthalmol. 49, S73–S78 (2004).
32. Modai, J. High-dose intravenous fluoroquinolones in the treatment of severe infections. J. Chemotherapy. 11, 478–485 (1999).
33. Dorr, T., Vulic, M. & Lewis, K. Ciprofloxacin causes persister formation by inducing the TisB toxin in Escherichia coli. PLoS Biol. 8, e1000317 (2010).
34. Kaspy, I. et al. HipA-mediated antibiotic persistence via phosphorylation of the glutamyl-tRNA-synthetase. Nat. Commun. 4, 3001 (2013).
35. Germain, E., Castro-Roa, D., Zenkin, N. & Gerdes, K. Molecular mechanism of bacterial persistence by HipA. Mol. Cell. 52, 248–254 (2013).
36. Tripathi, A., Dewan, P. C., Siddique, S. A. & Varadarajan, R. MazF-induced growth inhibition and persister generation in Escherichia coli. J. Biol. Chem. 289, 4191–4205 (2014).
37. Kwan, B. W., Valenta, J. A., Benedik, M. J. & Wood, T. K. Arrested protein synthesis increases persister-like cell formation. Antimicrob. Agents Chemother. 57, 1468–1473 (2013).
38. Volzing, K. G. & Brynildsen, M. P. Stationary phase persisters to ofloxacin sustain DNA damage and require repair systems only during recovery. mBio. 6, e00731–15 (2015).
39. Verstraeten, N. et al. Obg and membrane depolarization are part of a microbial bet-hedging strategy that leads to antibiotic tolerance. Mol. Cell. 59, 9–21 (2015).
40. Zaslaver, A. et al. A comprehensive library of fluorescent transcriptional reporters for Escherichia coli. Nat. Methods. 3, 623–628 (2006).
41. Sato, K., Inoue, Y., Fujii, T., Aoyama, H. & Mitsuhashi, S. Antibacterial activity of ofloxacin and its mode of action. Infection. 14, S226–S230 (1986).
42. Giardine, B. et al. Galaxy: a platform for interactive large-scale genome analysis. Genome Res. 15, 1451–1455 (2005).
43. Blankenberg, D. et al. Galaxy: a web-based genome analysis tool for experimentalists. Curr. Protoc. Mol. Biol. 89, 19.10.1–19.10.21 (2010).
44. Goecks, J., Nekrutenko, A., Taylor, J. & Galaxy Team. Galaxy: a comprehensive approach for supporting accessible, reproducible and transparent computational research in the life sciences. Genome Biol. 11, R86 (2010).
45. Langmead, B. & Salzberg, S. L. Fast gapped-read alignment with Bowtie 2. Nat. Methods. 9, 357–359 (2012).
46. Pratt, L. A. & Silhavy, T. J. The response regulator SprE controls the stability of RpoS. Proc. Natl. Acad. Sci. 93, 2488–2492 (1996).
47. Muffler, A., Fischer, D., Altuvia, S., Storz, G. & Hengge-Aronis, R. The response regulator RssB controls stability of the sigma(S) subunit of RNA polymerase in Escherichia coli. EMBO J. 15, 1333–1339 (1996).
48. Amato, S. M. & Brynildsen, M. P. Persister heterogeneity arising from a single metabolic stress. Curr. Biol. 25, 2090–2098 (2015).
49. Kim, J. S. et al. Selective killing of bacterial persisters by a single chemical compound without affecting normal antibiotic-sensitive cells. Antimicrob. Agents Chemother. 55, 5380–5383 (2011).
50. Conlon, B. P. et al. Activated ClpP kills persisters and eradicates a chronic biofilm infection. Nature. 503, 365–370 (2013).
51. Pan, J., Bahar, A. A., Syed, H. & Ren, D. Reverting antibiotic tolerance of Pseudomonas aeruginosa PAO1 persister cells by (Z)-4-bromo-5-(bromomethylene)-3-methylfuran-2(5H)-one. PLoS One. 7, e45778 (2012).
52. Wakamoto, Y. et al. Dynamic persistence of antibiotic-stressed mycobacteria. Science. 339, 91–95 (2013).
53. Deitz, W. H., Cook, T. M. & Goss, W. A. Mechanism of action of nalidixic acid on Escherichia Coli, III, Conditions required for lethality. J. Bacteriol. 91, 768–773 (1966).
54. Crumplin, G. C. & Smith, J. T. Nalidixic acid: an antibacterial paradox. Antimicrob. Agents Chemother. 8, 251–261 (1975).
55. Nollmann, M., Crisona, N. J. & Arimondo, P. B. Thirty years of Escherichia coli DNA gyrase: From in vivo function to single-molecule mechanism. Biochimie. 89, 490–499 (2007).
56. Grant, S. S., Kaufmann, B. B., Chand, N. S., Haseley, N. & Hung, D. T. Eradication of bacterial persisters with antibiotic-generated hydroxyl radicals. Proc. Natl. Acad. Sci. 109, 12147–12152 (2012).
57. De Groote, V. N. et al. Novel persistence genes in Pseudomonas aeruginosa identified by high-throughput screening. FEMS Microbiol. Lett. 297, 73–79 (2009).
58. Johnson, P. J. & Levin, B. R. Pharmacodynamics, population dynamics and the evolution of persistence in Staphylococcus aureus. PLoS Genet. 9, e1003123 (2013).
59. Hofsteenge, N., van Nimwegen, E. & Silander, O. K. Quantitative analysis of persister fractions suggests different mechanisms of formation among environmental isolates of E. coli. BMC Microbiol. 13, 25 (2013).